Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.40 -1.5% 92.20 91.20 91.60 93.60 90.00 92.40 1,042,807 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -29.4 -36.8 - 121

4d Pharma Share Discussion Threads

Showing 12801 to 12822 of 15725 messages
Chat Pages: Latest  521  520  519  518  517  516  515  514  513  512  511  510  Older
DateSubjectAuthorDiscuss
24/10/2020
11:10
Donald, how far in do you discuss DDDD?
showmethemoneyhoney01
24/10/2020
11:03
All, I mention 4D in this week's podcast, albeit you all know the drill... Please listen, share with your network and give us feedback hTTps://podcasts.apple.com/gb/podcast/episode-4/id1534289865?i=1000495889864 we are also on audible, google podcasts and direct from buzzsprout Thanks all. On 4D, we've got a week before the conference. Should be fun.
donald pond
24/10/2020
11:02
And Merck are apparently the biggest vaccine Pharma around and still they did not seem to jump at the opportuniy for Covid here, maybe seeing other possibilities like treatment. Developing vaccines is a really costly affair, and how long will it take?
thresholdbypass
24/10/2020
10:58
someuwin, I am not trying to diss your assertion, let me put it this way, there are not a lot of Big Pharma putting a lot of money and effort in developing vaccines. The current Covid race is a one off, high profile, very good PR, great financial conditions and administration conditions. All this is totally exceptional and has nothing to do with the regular way vaccines are developed. But once a vaccine is in the protfolio, it is obviously still making money. But look at it this way, even a vaccine like HPV, is two jabs in a life time, whilst any treatment has multiple usage. Just look at painkillers, enormoes amounts are sold every year and the costs are now purely production and extremely low
thresholdbypass
24/10/2020
10:31
Mr Roper, agree on Blautix and Covid. If they deliver on all this then sky is the limit.
frrinvest
24/10/2020
10:26
I would think 2bn bucks mkt cap is a pretty fair target. Perhaps 12mths away if progress continues as it has to date. Saying that, if they partner blautix, pick up another Merck type partner on oncology, prove Mrx5 is efficacious on as a mono therapy, and have a covid win with mrx4 we may need to revise our targets significantly higher. This would be a major league disruptive tech that on Nasdaq would demand a stratospheric valuation, double figure billions not unrealistic in a few years.
mr roper
24/10/2020
10:22
Kangaman I'm putting together a little spreadsheet to keep on top of the arbitrage opportunity Will put it up later
the stigologist
24/10/2020
10:17
Though they have given 13% of company @ £1.10, a rock bottom price, the positives are clear: 1. The near term funding issues are over, as it secures funds till 3Q 2021. This is long time in the case of 4D as so much is in the pipeline to come through in the next 12 months, least of all substantial payment from Merck on positive oncology data. This is going to be big and will take 4D valuation to the level they deserve. Not sure what this level is at present but those who are saying $2B+ may not be off the mark. 2. In almost an instance, the Nasdaq listing has effectively been pushed through, magic! 3. The costs and work associated with Nasdaq listing has been eliminated completely, magic! 4. 4D partnering an existing shell company (LOAC) can immediately commence marketing of LBPS prior to official listing approx. mid Jan 2021. On balance a very intelligent move. Onwards and upwards imho.
frrinvest
24/10/2020
09:02
Https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/4d-pharma-to-merge-with-chinese-acquisition-company-to-tap-us-market-60862782
bermudashorts
24/10/2020
08:35
That is a great find showmethemoneyhoney01, and indeed, you never know, those are the numbers we're looking for! :-) (smiling from it, not laughing at it)
thresholdbypass
24/10/2020
08:24
hTTps://twitter.com/lramseu/status/1319913179590393856?s=28 You never know!
showmethemoneyhoney01
24/10/2020
07:53
Is there an Arbitrage opportunity here??Potentially...
rastamouse
24/10/2020
07:35
LOAC up 3.21% yesterday. Looks like it hasn’t gone unnoticed.
johnveals
24/10/2020
07:30
Stig could you explain to a simpleton like me, why Loac is a cheap way into 4d please.
kangaman
24/10/2020
06:40
https://twitter.com/AimHardy/status/1319883086113476608?s=08
rastamouse
23/10/2020
22:28
You can but laoc on trading 212
gooner1886
23/10/2020
22:24
Have had same problem trying to buy $LOAC It now represents a v.cheap way into DDDD I suspect US retail investors not woken up to this story yet... must be v.tightly held I see Goldmans on the shareholder list. V.good sign.
the stigologist
23/10/2020
21:19
why magli?
dope007
23/10/2020
20:13
Cant buy Loac on ii on line so will check monday with Dealers.
magli
23/10/2020
19:16
And maybe diagnostics
thresholdbypass
23/10/2020
19:11
Vaccines for flu need to be updated regularly, costly bussiness, maybe HPV is an exception, I do not know, but really, treatments are the bees knees in terms of money
thresholdbypass
23/10/2020
19:06
Few 100k plus trades through showing late. Some good money coming into 4D now. Holding for a rerate back to 160p plus.
con90210
Chat Pages: Latest  521  520  519  518  517  516  515  514  513  512  511  510  Older
ADVFN Advertorial
Your Recent History
LSE
DDDD
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201205 13:14:05